KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (2016 - 2025)

Edwards Lifesciences has reported Shares Outstanding over the past 16 years, most recently at $580.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $580.7 million for Q4 2025, down 1.34% from a year ago — trailing twelve months through Dec 2025 was $580.7 million (down 1.34% YoY), and the annual figure for FY2025 was $580.7 million, down 1.34%.
  • Shares Outstanding for Q4 2025 was $580.7 million at Edwards Lifesciences, roughly flat from $580.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for EW hit a ceiling of $657.6 million in Q2 2025 and a floor of $580.7 million in Q3 2025.
  • Median Shares Outstanding over the past 5 years was $646.0 million (2022), compared with a mean of $638.0 million.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 5212.5% in 2021 and later dropped 11.25% in 2025.
  • Edwards Lifesciences' Shares Outstanding stood at $642.0 million in 2021, then rose by 0.67% to $646.3 million in 2022, then rose by 0.65% to $650.5 million in 2023, then decreased by 9.52% to $588.6 million in 2024, then dropped by 1.34% to $580.7 million in 2025.
  • The last three reported values for Shares Outstanding were $580.7 million (Q4 2025), $580.7 million (Q3 2025), and $657.6 million (Q2 2025) per Business Quant data.